University of California, Berkeley Press:
August 27, 2020
Drs. Eva Harris and Josefina Coloma of the Division of Infectious Diseases and Immunization at UC Berkeley School of Public Health received a $7.78 million five-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), from the National Institutes of Health (NIH), to publish the Asian and American Center for Enhanced Arbovirus Research and Surveillance (A2CARES; 1U01AI151788).
The new centre is part of the Emerging Infectious Disease Research Centers (CREID), a coordinated network of 10 centers in regions of the world where outbreaks of emerging and re-emerging infectious diseases are most likely to occur.groups of researchers will monitor pathogens/guests; examine pathogen transmission, pathogenesis and immune responses in the host; and expand reagents and diagnostic tests for increased detection of emerging pathogens and their vectors.
Research Triangle Institute (RTI), a non-profit organization with regional and allocation offices in more than 75 countries, and Duke University, home of the Duke Human Vaccine Institute, will serve as a CREID Coordination Center (RTI/Duke CC).more information, visit: creid-network.org.
A2CARES is a consortium of world-renowned scholars in arbovirology, epidemiology, immunology, viral diagnosis, phylogenetics and clinical studies in Nicaragua, Ecuador, Sri Lanka, the United Kingdom and the United States, whose primary objective is to expand an interconnected network of clinical sites and laboratories that serve as the basis for surgery programmes, compare arboviral diseases in geographical regions, expand and put into force molecular and serological testing methods and respond well and successfully to new epidemics.”A very timely network of consortia is needed to help the global reaction and research of new and existing infectious diseases; our team has been running in combination for decades and is excited and ready for the challenge,” says Dr. Harris
The consortium leverages the study infrastructure and experience in long-term, hospital-based cohort studies in Nicaragua, Ecuador and Sri Lanka.With 3 decades of collaborative studies abroad and more than two hundred joint publications, A2CARES researchers have extensive experience in preparing and responding to epidemics in close collaboration with local and foreign fitness government and NIAID.
The COVID-19 pandemic has demonstrated the ability of new human pathogens to emerge and cause widespread epidemics with new and potentially serious clinical outcomes.The existing pandemic underscores the urgent need for flexible and coordinated systems capable of responding to emerging pathogens and providing high-quality clinical samples and knowledge for multidisciplinary study efforts.A2CARES and CREID will reduce the long-term global threat of new viruses by building a global capacity to respond to these threats.
A2CARES key spouse and workers’ establishments include:
This press release produced through the University of California, Berkeley.The reviews expressed here are those of the author.
Loading…